Indications and Purposes
| 1 Indications And Usage Krystexxa ® (Pegloticase) Is A Pegylated Uric Acid Specific Enzyme Indicated For The Treatment Of Chronic Gout In Adult Patients Refractory To Conventional Therapy. Gout Refractory To Conventional Therapy Occurs In Patients Who Have Failed To Normalize Serum Uric Acid And Whose Signs And Symptoms Are Inadequately Controlled With Xanthine Oxidase Inhibitors At The Maximum Medically Appropriate Dose Or For Whom These Drugs Are Contraindicated. Krystexxa ® (Pegloticase) Is A Pegylated Uric Acid Specific Enzyme Indicated For The Treatment Of Chronic Gout In Adult Patients Refractory To Conventional Therapy. ( 1 ) Important Limitations Of Use: Krystexxa Is Not Recommended For The Treatment Of Asymptomatic Hyperuricemia. ( 1 ) Important Limitations Of Use: Krystexxa Is Not Recommended For The Treatment Of Asymptomatic Hyperuricemia. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Pegloticase |